Clinical data | |
---|---|
Other names | (3R,4R,5R)-4-(Benzyloxy)-5-[1,2-bis(benzyloxy)ethyl]-2-ethoxyoxolan-3-ol |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.030.612 |
Chemical and physical data | |
Formula | C29H34O6 |
Molar mass | 478.585 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Tribenoside (Glyvenol) is a vasoprotective drug used to treat hemorrhoids.[1] It has mild anti-inflammatory, analgesic, and wound healing properties.[2] Tribenoside stimulates laminin α5 production and laminin-332 deposition to help repair the basement membrane during the wound healing process.[3] It is a mixture of the α- and β-anomers.[citation needed]
Tribenoside has been shown to induce drug hypersensitivity syndrome in association with CMV reactivation.[4]
{{cite journal}}
: CS1 maint: multiple names: authors list (link)